Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Drug Discov. 2010 Dec;9(12):901-2. doi: 10.1038/nrd3340.

Accelerating orphan drug development.

Author information

  • 1Office of the Commissioner, Office of Orphan Products Development, Silver Spring, Maryland 20993, USA. timothy.cote@fda.hhs.gov

Abstract

Interest in developing drugs for rare diseases has increased substantially in recent years. This article from the US Food and Drug Administration highlights the role of regulators in catalysing further progress in this field.

Comment on

PMID:
21119719
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk